Equity

Global active equity platform: High-conviction strategies for long-term growth

Why Janus Henderson Investors for active equity investing?


Janus Henderson’s global active equity platform delivers high-conviction strategies designed to help clients achieve long-term growth and risk-adjusted returns.

Our experienced investment professionals leverage deep fundamental research and global insights to build equity solutions that aim to outperform benchmarks.

hand with healthcare plus sign

Active platform, global reach

hand with healthcare plus sign

Active platform, global reach

A truly global, actively managed equity platform, investing with high-conviction across all regions and styles.

hands holding a globe

Focused investment expertise

hands holding a globe

Focused investment expertise

Our experienced equity specialists drive high-conviction, research-driven strategies. Their focused expertise allows for agile decision-making.

people icons in a circle, lines are connecting each other

A history of delivering performance for clients

people icons in a circle, lines are connecting each other

A history of delivering performance for clients

As a pure active asset manager, our mission is to deliver long-term, risk-adjusted returns that exceed benchmarks and peer averages.

Our equity platform


$256.6bn

Equity AUM

155

Equities investment professionals

20

Average years' experience

As of December 31, 2025

Meet our leaders


Invest in a brighter future, today.

Investment heads Marc Pinto, CFA, and Lucas Klein discuss the Janus Henderson difference, where world-class investment talent meets a commitment to your financial goals.

Hear them outline how our disciplined approach to equities, focused on rigorous stock selection and risk management, is driven by an unwavering dedication to active investing.

Featured products


JXX

Transformational Growth ETF


JHAI

Global Artificial Intelligence ETF


JSMD

Small/Mid Cap Growth Alpha ETF


JMGRX

Enterprise Fund


JIGFX

Overseas Fund


HFQIX

Global Equity Income Fund


Differentiated insights


Data center power: Why the key risk is under delivery, not overbuild

Why the prevailing narrative of new energy-generation capacity exceeding AI data center demand could be off the mark.

Pharma and biotech in 2026: A catalyst‑rich year ahead

With innovation back in focus, a dense slate of drug launches, data readouts, and regulatory decisions makes 2026 a consequential year for pharma and biotech.

Market moves & themes that mattered: February 2026

A monthly market update featuring global equity and fixed income performance, sector and asset class trends, and key themes shaping the investment landscape.

Insights delivered to your inbox


To implement any of these solutions or to find out more about how they can help you excel, contact your Janus Henderson sales director.

Investing in a
Brighter Future
Together